EXERCISE CAPACITY IN PATIENTS WITH CORONARY HEART DISEASE AND PERIPHERAL ARTERY DISEASE, RECEIVING LONG-TERM MILDRONATE THERAPY
The paper presents the results of 3 prospective, randomised, double-blind, placebo-controlled trials of patients with coronary heart disease (CHD) and peripheral artery disease (PAD). The aim was to compare veloergometry parameters and skeletal muscle strength in CAD patients, as well as exercise ca...
Saved in:
Main Authors: | V. Ya. Dzerve, Yu. M. Pozdnyakov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2011-02-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1085 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological prolyl hydroxylase inhibition enhances high‐intensity exercise capacity in mice
by: Koji Takemura, et al.
Published: (2025-07-01) -
Mildronate effectiveness in post-hospital rehabilitation of patients with myocardial infarction
by: V. P. Mikhin, et al.
Published: (2012-04-01) -
HYPOXIA-HYPEROXIA ADAPTATION AND INCREASED EXERCISE CAPACITY IN PATIENTS WITH CORONARY HEART DISEASE
by: O. S. Glazachev, et al.
Published: (2014-02-01) -
Mildronate in cardiology practice – current evidence, ongoing research, and future perspectives
by: V. P. Mikhin, et al.
Published: (2012-02-01) -
Advancements of physical exercise and intestinal microbiota and their potential mechanisms
by: Rendong Li, et al.
Published: (2025-07-01)